Table:
begin	end	state
1	13	cytoplasmic
14	36	transmembrane
37	47	non-cytoplasmic
48	66	transmembrane
67	95	cytoplasmic
96	114	transmembrane
115	119	non-cytoplasmic
120	142	transmembrane
143	147	cytoplasmic
148	167	transmembrane
168	172	non-cytoplasmic
173	193	transmembrane
194	199	cytoplasmic
200	220	transmembrane
221	263	non-cytoplasmic
264	283	transmembrane
284	314	cytoplasmic
315	338	transmembrane
339	352	non-cytoplasmic
353	378	transmembrane
379	389	cytoplasmic
390	407	transmembrane
408	426	non-cytoplasmic

Input:
>Pf6N2E2_3578
MSAANKPLDIKQSVIDAILAGLISLIVFGPIVGVVLDGYSFNLQPARVGWLVAIVMIGRF
ALSLFLQTPKGLKILQGFESTGSGVHVLPPDYKSRLRWIIPALIVIAIVFPFFANKYVLT
VVILGLIYVLLGLGLNIVVGLAGLLDLGYVAFYAIGAYGLALGYQYLGLGFWTVLPLAAI
AAAMAGCILGFPVLRMHGDYLAIVTLGFGEIIRLVLNNWLSFTGGPNGMPVPSPTFLGLE
FGRRAKDGGVPFHEFFGIDYNPNIKFLFIYIVLFITVLLVLYVKHRLTRMPVGRAWEALR
EDEIACRSMGLNHVLVKLSAFTIGASTAGLAGVFFASYQGFVNPSSFTFFESALILAIVV
LGGMGSTVGVVIAAFVLTVAPELLRSFSEYRVLLFGVLMVLMMIWRPRGLIRISRTGVTP
RKGVAP

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server